Literature DB >> 8660321

The clonal progression in the neoplastic process of nasopharyngeal carcinoma.

X Jiang1, K T Yao.   

Abstract

The clonality of a total of 70 human nasopharyngeal carcinomas (NPC) was analyzed using the structure of the terminal fragment of episomal Epstein-Barr virus (EBV). Thirty female samples heterozygous for the BstXI polymorphism of the phosphoglycerokinase (PGK) gene were analyzed using polymerase chain reaction (PCR) amplification of X-chromosome linked PGK gene for restriction fragment length polymorphism (RFLP). All NPC samples analyzed were shown to be monoclonal, with two exceptions that were polyclonal. Clonal determination was also performed for non-cancerous cell populations: normal, and simple hyperplastic, grade I (mild) and grade II-III (severe) atypical hyperplastic epithelia. It was found that the normal and simple hyperplastic and 3 grade I (mild) atypical hyperplastic epithelia were polyclonal, whereas the grade II-III (severe) atypical hyperplastic samples were monoclonal. The analysis of the clonality of various stages in the neoplastic process suggested that NPC might originate from several cells, after clonal selection; finally a large majority of NPC has been demonstrated to be monoclonal, also indicating that the alteration of clonal nature might have occurred at a very early stage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660321     DOI: 10.1006/bbrc.1996.0556

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  A hemizygous short tandem repeat polymorphism 3' to the human phosphoglycerate kinase gene.

Authors:  D E Riley; I R Cho; J N Krieger
Journal:  Mol Biol Rep       Date:  1999-08       Impact factor: 2.316

Review 3.  Epstein-Barr virus infection and human malignancies.

Authors:  G Niedobitek; N Meru; H J Delecluse
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.